The University of Chicago Header Logo

Connection

Jeffrey Hubbell to Mice

This is a "connection" page, showing publications Jeffrey Hubbell has written about Mice.
Connection Strength

2.658
  1. Blocking antibodies against integrin-a3, -aM, and -aMß2 de-differentiate myofibroblasts, and improve lung fibrosis and kidney fibrosis. Sci Rep. 2024 09 16; 14(1):21623.
    View in: PubMed
    Score: 0.090
  2. Injectable butyrate-prodrug micelles induce long-acting immune modulation and prevent autoimmune arthritis in mice. J Control Release. 2024 Aug; 372:281-294.
    View in: PubMed
    Score: 0.089
  3. Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia. Blood Adv. 2024 Apr 09; 8(7):1747-1759.
    View in: PubMed
    Score: 0.088
  4. A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice. Nat Biomed Eng. 2024 May; 8(5):611-627.
    View in: PubMed
    Score: 0.088
  5. Glycosylation-modified antigens as a tolerance-inducing vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy. Cell Rep Med. 2024 01 16; 5(1):101346.
    View in: PubMed
    Score: 0.086
  6. Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses. Nat Biomed Eng. 2023 09; 7(9):1142-1155.
    View in: PubMed
    Score: 0.084
  7. Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker. Nat Biomed Eng. 2022 07; 6(7):819-829.
    View in: PubMed
    Score: 0.077
  8. Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant. Biomaterials. 2021 11; 278:121159.
    View in: PubMed
    Score: 0.074
  9. Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance. Front Immunol. 2021; 12:714842.
    View in: PubMed
    Score: 0.074
  10. Engineered bridge protein with dual affinity for bone morphogenetic protein-2 and collagen enhances bone regeneration for spinal fusion. Sci Adv. 2021 06; 7(24).
    View in: PubMed
    Score: 0.072
  11. Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models. Arthritis Rheumatol. 2021 05; 73(5):769-778.
    View in: PubMed
    Score: 0.071
  12. Soluble N-Acetylgalactosamine-Modified Antigens Enhance Hepatocyte-Dependent Antigen Cross-Presentation and Result in Antigen-Specific CD8+ T Cell Tolerance Development. Front Immunol. 2021; 12:555095.
    View in: PubMed
    Score: 0.071
  13. Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction. Sci Immunol. 2021 02 26; 6(56).
    View in: PubMed
    Score: 0.071
  14. Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nat Biomed Eng. 2021 05; 5(5):387-398.
    View in: PubMed
    Score: 0.069
  15. Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-a antibody in a murine model of rheumatoid arthritis. Arthritis Res Ther. 2019 12 23; 21(1):298.
    View in: PubMed
    Score: 0.065
  16. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019 12; 5(12):eaay1357.
    View in: PubMed
    Score: 0.065
  17. Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy. Sci Adv. 2019 08; 5(8):eaaw6081.
    View in: PubMed
    Score: 0.064
  18. Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity. Nat Mater. 2019 02; 18(2):175-185.
    View in: PubMed
    Score: 0.061
  19. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses. J Allergy Clin Immunol. 2017 Nov; 140(5):1339-1350.
    View in: PubMed
    Score: 0.054
  20. Difference in suitable mechanical properties of three-dimensional, synthetic scaffolds for self-renewing mouse embryonic stem cells of different genetic backgrounds. J Biomed Mater Res B Appl Biomater. 2017 Nov; 105(8):2261-2268.
    View in: PubMed
    Score: 0.051
  21. Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses. Vaccine. 2016 05 05; 34(21):2453-2459.
    View in: PubMed
    Score: 0.050
  22. Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens. Sci Rep. 2015 Oct 29; 5:15907.
    View in: PubMed
    Score: 0.049
  23. Crystalline Oligo(ethylene sulfide) Domains Define Highly Stable Supramolecular Block Copolymer Assemblies. ACS Nano. 2015 Jul 28; 9(7):6872-81.
    View in: PubMed
    Score: 0.048
  24. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine. Sci Rep. 2015 Feb 24; 5:8569.
    View in: PubMed
    Score: 0.047
  25. Device design and materials optimization of conformal coating for islets of Langerhans. Proc Natl Acad Sci U S A. 2014 Jul 22; 111(29):10514-9.
    View in: PubMed
    Score: 0.045
  26. Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164. Proc Natl Acad Sci U S A. 2014 May 13; 111(19):6952-7.
    View in: PubMed
    Score: 0.044
  27. SPARC-derived protease substrates to enhance the plasmin sensitivity of molecularly engineered PEG hydrogels. Biomaterials. 2011 Feb; 32(5):1301-10.
    View in: PubMed
    Score: 0.035
  28. Drug development: Longer-lived proteins. Nature. 2010 Oct 28; 467(7319):1051-2.
    View in: PubMed
    Score: 0.035
  29. Improving protein pharmacokinetics by engineering erythrocyte affinity. Mol Pharm. 2010 Dec 06; 7(6):2141-7.
    View in: PubMed
    Score: 0.034
  30. Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2. Biomaterials. 2010 Oct; 31(30):7836-45.
    View in: PubMed
    Score: 0.034
  31. In vitro uptake of amphiphilic, hydrogel nanoparticles by J774A.1 cells. J Biomed Mater Res A. 2010 Jun 15; 93(4):1557-65.
    View in: PubMed
    Score: 0.034
  32. Functionalization of polysulfide nanoparticles and their performance as circulating carriers. Biomaterials. 2008 Apr; 29(12):1958-66.
    View in: PubMed
    Score: 0.029
  33. Membrane-localized neoantigens predict the efficacy of cancer immunotherapy. Cell Rep Med. 2023 08 15; 4(8):101145.
    View in: PubMed
    Score: 0.021
  34. Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles. Nat Biomed Eng. 2023 Jan; 7(1):38-55.
    View in: PubMed
    Score: 0.020
  35. Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas. Sci Adv. 2021 03; 7(13).
    View in: PubMed
    Score: 0.018
  36. Growth factors with enhanced syndecan binding generate tonic signalling and promote tissue healing. Nat Biomed Eng. 2020 04; 4(4):463-475.
    View in: PubMed
    Score: 0.016
  37. Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes. Nat Biomed Eng. 2019 10; 3(10):817-829.
    View in: PubMed
    Score: 0.016
  38. The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing. Blood. 2019 06 13; 133(24):2559-2569.
    View in: PubMed
    Score: 0.016
  39. A bioactive injectable bulking material; a potential therapeutic approach for stress urinary incontinence. Biomaterials. 2019 06; 206:41-48.
    View in: PubMed
    Score: 0.015
  40. Murine macrophage behavior on peptide-grafted polyethyleneglycol-containing networks. Biotechnol Bioeng. 1998 Jul 05; 59(1):2-9.
    View in: PubMed
    Score: 0.015
  41. Modified Magnesium Hydroxide Nanoparticles Inhibit the Inflammatory Response to Biodegradable Poly(lactide- co-glycolide) Implants. ACS Nano. 2018 07 24; 12(7):6917-6925.
    View in: PubMed
    Score: 0.015
  42. Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol. Am J Transplant. 2018 03; 18(3):590-603.
    View in: PubMed
    Score: 0.014
  43. Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein. Virology. 2017 12; 512:161-171.
    View in: PubMed
    Score: 0.014
  44. Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responses. Biomaterials. 2017 07; 132:48-58.
    View in: PubMed
    Score: 0.013
  45. Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling. Biomaterials. 2017 07; 131:160-175.
    View in: PubMed
    Score: 0.013
  46. Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice. Sci Rep. 2015 Sep 21; 5:14274.
    View in: PubMed
    Score: 0.012
  47. Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice. Biotechnol Bioeng. 2015 Sep; 112(9):1916-26.
    View in: PubMed
    Score: 0.012
  48. 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice. Cancer Immunol Immunother. 2015 Aug; 64(8):1033-46.
    View in: PubMed
    Score: 0.012
  49. Bioluminescent and micro-computed tomography imaging of bone repair induced by fibrin-binding growth factors. Acta Biomater. 2014 Oct; 10(10):4377-89.
    View in: PubMed
    Score: 0.011
  50. Clonal, self-renewing and differentiating human and porcine urothelial cells, a novel stem cell population. PLoS One. 2014; 9(2):e90006.
    View in: PubMed
    Score: 0.011
  51. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science. 2014 Feb 21; 343(6173):885-8.
    View in: PubMed
    Score: 0.011
  52. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes. Cancer Immunol Res. 2014 May; 2(5):436-47.
    View in: PubMed
    Score: 0.011
  53. Culture of preantral follicles in poly(ethylene) glycol-based, three-dimensional hydrogel: a relationship between swelling ratio and follicular developments. J Tissue Eng Regen Med. 2015 Mar; 9(3):319-23.
    View in: PubMed
    Score: 0.011
  54. Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. Proc Natl Acad Sci U S A. 2013 Dec 03; 110(49):19902-7.
    View in: PubMed
    Score: 0.011
  55. Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials. 2014 Jan; 35(2):814-24.
    View in: PubMed
    Score: 0.011
  56. In situ cell manipulation through enzymatic hydrogel photopatterning. Nat Mater. 2013 Nov; 12(11):1072-8.
    View in: PubMed
    Score: 0.011
  57. Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility. Biomaterials. 1993 Oct; 14(13):1008-16.
    View in: PubMed
    Score: 0.011
  58. VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy. Am J Pathol. 2013 Nov; 183(5):1596-1607.
    View in: PubMed
    Score: 0.011
  59. Preparation of well-defined ibuprofen prodrug micelles by RAFT polymerization. Biomacromolecules. 2013 Sep 09; 14(9):3314-20.
    View in: PubMed
    Score: 0.010
  60. Proangiogenic hydrogels within macroporous scaffolds enhance islet engraftment in an extrahepatic site. Tissue Eng Part A. 2013 Dec; 19(23-24):2544-52.
    View in: PubMed
    Score: 0.010
  61. The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165. Biomaterials. 2013 Aug; 34(24):5958-68.
    View in: PubMed
    Score: 0.010
  62. Proteolytic processing regulates placental growth factor activities. J Biol Chem. 2013 Jun 21; 288(25):17976-89.
    View in: PubMed
    Score: 0.010
  63. Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS One. 2013; 8(4):e61646.
    View in: PubMed
    Score: 0.010
  64. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles. Biomaterials. 2013 Jun; 34(17):4339-46.
    View in: PubMed
    Score: 0.010
  65. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci U S A. 2013 Mar 19; 110(12):4563-8.
    View in: PubMed
    Score: 0.010
  66. A high-throughput nanoimmunoassay chip applied to large-scale vaccine adjuvant screening. Integr Biol (Camb). 2013 Apr; 5(4):650-8.
    View in: PubMed
    Score: 0.010
  67. Engineering antigens for in situ erythrocyte binding induces T-cell deletion. Proc Natl Acad Sci U S A. 2013 Jan 02; 110(1):E60-8.
    View in: PubMed
    Score: 0.010
  68. Sorting live stem cells based on Sox2 mRNA expression. PLoS One. 2012; 7(11):e49874.
    View in: PubMed
    Score: 0.010
  69. Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization. Vaccine. 2012 Dec 14; 30(52):7541-6.
    View in: PubMed
    Score: 0.010
  70. Improving the osteogenic potential of BMP-2 with hyaluronic acid hydrogel modified with integrin-specific fibronectin fragment. Biomaterials. 2013 Jan; 34(3):704-12.
    View in: PubMed
    Score: 0.010
  71. Long-term maintenance of mouse embryonic stem cell pluripotency by manipulating integrin signaling within 3D scaffolds without active Stat3. Biomaterials. 2012 Dec; 33(35):8934-42.
    View in: PubMed
    Score: 0.010
  72. Polymer micelles with pyridyl disulfide-coupled antigen travel through lymphatics and show enhanced cellular responses following immunization. Acta Biomater. 2012 Sep; 8(9):3210-7.
    View in: PubMed
    Score: 0.010
  73. Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. Biomaterials. 2012 Sep; 33(26):6211-9.
    View in: PubMed
    Score: 0.010
  74. Embryonic stem cell-based cardiopatches improve cardiac function in infarcted rats. Stem Cells Transl Med. 2012 Mar; 1(3):248-60.
    View in: PubMed
    Score: 0.009
  75. Tissue response to intraperitoneal implants of polyethylene oxide-modified polyethylene terephthalate. Biomaterials. 1992; 13(8):505-10.
    View in: PubMed
    Score: 0.009
  76. Poly(ethylene oxide)-graft-poly(L-lysine) copolymers to enhance the biocompatibility of poly(L-lysine)-alginate microcapsule membranes. Biomaterials. 1992; 13(12):863-70.
    View in: PubMed
    Score: 0.009
  77. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A. 2011 Nov 01; 108(44):E989-97.
    View in: PubMed
    Score: 0.009
  78. PEG-b-PPS-b-PEI micelles and PEG-b-PPS/PEG-b-PPS-b-PEI mixed micelles as non-viral vectors for plasmid DNA: tumor immunotoxicity in B16F10 melanoma. Biomaterials. 2011 Dec; 32(36):9839-47.
    View in: PubMed
    Score: 0.009
  79. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med. 2011 Sep 14; 3(100):100ra89.
    View in: PubMed
    Score: 0.009
  80. Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival. J Control Release. 2011 Dec 10; 156(2):154-60.
    View in: PubMed
    Score: 0.009
  81. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine. 2011 Sep 16; 29(40):6959-66.
    View in: PubMed
    Score: 0.009
  82. A collagen-poly(lactic acid-co-?-caprolactone) hybrid scaffold for bladder tissue regeneration. Biomaterials. 2011 Jun; 32(16):3969-76.
    View in: PubMed
    Score: 0.009
  83. Engineering complement activation on polypropylene sulfide vaccine nanoparticles. Biomaterials. 2011 Mar; 32(8):2194-203.
    View in: PubMed
    Score: 0.009
  84. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. Vaccine. 2011 Jan 17; 29(4):804-12.
    View in: PubMed
    Score: 0.009
  85. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation. Vaccine. 2010 Nov 23; 28(50):7897-906.
    View in: PubMed
    Score: 0.009
  86. Engineered aprotinin for improved stability of fibrin biomaterials. Biomaterials. 2011 Jan; 32(2):430-8.
    View in: PubMed
    Score: 0.009
  87. Engineering integrin signaling for promoting embryonic stem cell self-renewal in a precisely defined niche. Biomaterials. 2010 Feb; 31(6):1219-26.
    View in: PubMed
    Score: 0.008
  88. Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials. 2009 Feb; 30(6):1089-97.
    View in: PubMed
    Score: 0.008
  89. Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. Nat Mater. 2008 Mar; 7(3):248-54.
    View in: PubMed
    Score: 0.007
  90. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials. 2008 Apr; 29(11):1720-9.
    View in: PubMed
    Score: 0.007
  91. Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells. Biomaterials. 2008 Feb; 29(4):427-37.
    View in: PubMed
    Score: 0.007
  92. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol. 2007 Oct; 25(10):1159-64.
    View in: PubMed
    Score: 0.007
  93. PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules. 2007 Jun; 8(6):1966-72.
    View in: PubMed
    Score: 0.007
  94. Analysis of progenitor cell-scaffold combinations by in vivo non-invasive photonic imaging. Biomaterials. 2007 Jun; 28(17):2718-28.
    View in: PubMed
    Score: 0.007
  95. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release. 2006 May 01; 112(1):26-34.
    View in: PubMed
    Score: 0.006
  96. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A. 2006 Feb 21; 103(8):2506-11.
    View in: PubMed
    Score: 0.006
  97. Pattern stability under cell culture conditions--a comparative study of patterning methods based on PLL-g-PEG background passivation. Biomaterials. 2006 Apr; 27(12):2534-41.
    View in: PubMed
    Score: 0.006
  98. 3D morphology of cell cultures: a quantitative approach using micrometer synchrotron light tomography. Microsc Res Tech. 2005 Apr 15; 66(6):289-98.
    View in: PubMed
    Score: 0.006
  99. Poly (4-vinylimidazole) as nonviral gene carrier: in vitro and in vivo transfection. Acta Biomater. 2005 Mar; 1(2):165-72.
    View in: PubMed
    Score: 0.006
  100. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res. 2004 Apr 30; 94(8):1124-32.
    View in: PubMed
    Score: 0.005
  101. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 1999 May-Jun; 8(3):293-306.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.